Study of MAGE-1 Antigen in Lung Tumors
Author Information
Author(s): Jungbluth A A, Stockert E, Chen Y-T, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Busam K J, Old L J
Primary Institution: Ludwig Institute for Cancer Research at Memorial Sloan-Kettering Cancer Center
Hypothesis
The study investigates the expression pattern of MAGE-1 antigen in lung tumors using a monoclonal antibody.
Conclusion
MAGE-1 is expressed heterogeneously in lung tumors, indicating it may not be a reliable target for immunotherapy.
Supporting Evidence
- MA454 was positive in 19 out of 59 lung tumor cases, indicating a 32% expression rate.
- MAGE-1 mRNA was found in 32% of the cases available for RT-PCR.
- 15 out of 19 MA454-reactive tumors showed a highly heterogeneous pattern of expression.
Takeaway
The researchers looked at a special protein in lung tumors and found it shows up in different amounts, which means it might not be a good target for treatment.
Methodology
Immunohistochemical analysis and RT-PCR were used to assess MAGE-1 expression in lung tumors.
Limitations
The study may not fully represent all lung tumors due to the heterogeneous expression of MAGE-1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website